This webinar wassponsored by Eli Lilly and Company.

Learning Objectives:

• Understand the latest advancements and clinical trials in the eBC setting, including optimal management strategies for new therapies.
• Learn how digital tools and institutional approaches can support patient care and AE management.
• Appreciate the impact of peer support networks on patient experiences and outcomes in breast cancer care and identify best practices for leveraging these networks.

Agenda:

• Introduction – Prof. Maryam Lustberg (Session Chair)
• Advances in Targeted Therapy for High-Risk Early-Stage HR+/HER2- Breast Cancer – Prof. Hope Rugo
• Digital Tools and Institutional Experiences in Decision Support and Managing Adverse Events (AEs) – Prof. Andreas Charalambous
• Balancing Innovation and Personal Choice for Optimal Clinical Outcomes and Quality of Life - Stacey Tinianov, MPH (Patient Partner)
• Q & A